| |
| |
|
| Insider
Information: |
Rocamboli Stephen |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
70,108 |
|
|
Indirect Shares
|
997,371 |
|
|
| Direct
Value |
$36,762 |
|
|
|
Indirect Value
|
$2,158 |
|
|
| Total
Shares |
1,067,479 |
|
|
| Total
Value |
$38,920 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
3
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
3
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
 -27.7%
|
-147.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vioquest Pharmaceuticals |
VOQP |
Secretary, Director |
2008-01-14 |
15,500 |
2008-01-14 |
719,335 |
Premium* |
|
|
Velcera Inc |
VLCR |
Officer, Director |
2007-02-27 |
5,347 |
2007-02-27 |
278,036 |
Premium* |
|
|
Tff Pharmaceuticals, Inc. |
TFFP |
Director |
2023-08-15 |
36,000 |
2020-11-10 |
0 |
Premium* |
|
|
Esperion Therapeutics, Inc. |
ESPR |
Director |
2023-06-15 |
13,261 |
2023-05-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TFFP |
Tff Pharmaceuticals, Inc. |
Director |
– • – |
2023-08-15 |
4 |
B |
$0.25 |
$5,000 |
D/D |
20,000 |
36,000 |
2.39 |
% |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,150 |
13,261 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2023-05-10 |
4 |
B |
$1.50 |
$12,126 |
D/D |
8,111 |
8,111 |
2.39 |
% |
|
| TFFP |
Tff Pharmaceuticals, Inc. |
Director |
– • – |
2023-03-10 |
4 |
B |
$0.80 |
$10,433 |
D/D |
13,000 |
16,000 |
2.39 |
% |
|
| TFFP |
Tff Pharmaceuticals, Inc. |
Director |
– • – |
2022-05-16 |
4 |
B |
$4.54 |
$13,620 |
D/D |
3,000 |
18,722 |
2.39 |
% |
|
| TFFP |
Tff Pharmaceuticals, Inc. |
Director |
– • – |
2021-03-15 |
4 |
S |
$16.85 |
$337,101 |
D/D |
(20,006) |
15,722 |
0 |
% |
|
| TFFP |
Tff Pharmaceuticals, Inc. |
Director |
– • – |
2021-03-15 |
4 |
OE |
$2.50 |
$63,140 |
D/D |
20,006 |
35,728 |
0 |
- |
|
| TFFP |
Tff Pharmaceuticals, Inc. |
Director |
– • – |
2020-11-11 |
4 |
S |
$15.76 |
$247,732 |
D/D |
(15,722) |
0 |
0 |
% |
|
| TFFP |
Tff Pharmaceuticals, Inc. |
Director |
– • – |
2020-11-11 |
4 |
OE |
$2.50 |
$39,305 |
D/D |
15,722 |
15,722 |
0 |
- |
|
| TFFP |
Tff Pharmaceuticals, Inc. |
Director |
– • – |
2020-11-10 |
4 |
S |
$15.14 |
$322,106 |
D/D |
(21,278) |
0 |
0 |
% |
|
| TFFP |
Tff Pharmaceuticals, Inc. |
Director |
– • – |
2020-11-10 |
4 |
OE |
$2.50 |
$53,195 |
D/D |
21,278 |
21,278 |
0 |
- |
|
| VOQP |
Vioquest Pharmaceuticals |
Secretary |
• • – |
2008-01-14 |
4 |
B |
$0.11 |
$1,705 |
D/D |
15,500 |
15,500 |
2.73 |
- |
|
| VLCR |
Velcera Inc |
SecretaryOfficer |
• • – |
2007-02-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,347 |
|
- |
|
| VLCR |
Velcera Inc |
SecretaryOfficer |
• • – |
2007-02-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
278,036 |
|
- |
|
| VOQP |
Vioquest Pharmaceuticals |
Director |
– • – |
2005-10-18 |
4 |
A |
$0.00 |
$0 |
I/I |
616,636 |
719,335 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
